# Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1

> **NCT03507127** · PHASE2 · TERMINATED · sponsor: **Brown University** · enrollment: 5 (actual)

## Conditions studied

- Tobacco Dependence

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03507127
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Low rate of enrollment
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507127, "Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03507127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*